NCT02614482 Extension Study of Fesoterodine for Overactive Bladder Syndrome in Children. Status COMPLETED Phase PHASE3
NCT02601287 A Safety and Efficacy Study of Botulinum Toxin Type A (BOTOX®) to Treat Urinary Incontinence Due to Neurogenic Detrusor Overactivity or Overactive Bladder in Korean Patients Status COMPLETED Phase PHASE4
NCT02600715 Reduction of Bladder Injection Pain With Belladonna Opiate Suppository Status COMPLETED Phase PHASE4
NCT02590250 A Safety and Efficacy Study of BOTOX® (Botulinum Toxin Type A) in Patients With Urinary Incontinence Due to Neurogenic Detrusor Overactivity or Overactive Bladder in India Status COMPLETED Phase N/A
NCT02583529 Neurogenic Overactive Bladder Treatment on Parkinson's Disease Through Back Tibial Nerve Electrostimulation Status UNKNOWN Phase EARLY_PHASE1
NCT02570035 Specified Drug Use-results Survey of Betanis Tablets for Patients With Coexisting Cardiovascular Disease Status COMPLETED Phase N/A
NCT02540798 Do Patient Anxiety Levels Decrease Urodynamic Test Reproducibility? Status COMPLETED Phase N/A
NCT02526979 A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Mirabegron Oral Suspension in Pediatric Subjects From 3 to Less Than 12 Years of Age With Neurogenic Detrusor Overactivity (NDO) or Overactive Bladder (OAB) Status COMPLETED Phase PHASE1
NCT02524769 The Estrogen Impact on Overactive Bladder Syndrome: Female Pelvic Floor Microbiomes and Antimicrobial Peptides Status COMPLETED Phase NA
NCT02522936 Use of Biotene Moisturizing Mouth Spray for Xerostomia Associated With Oral Oxybutynin Use Status WITHDRAWN Phase PHASE4
NCT02502838 The Effect of an Additional Stress Incontinence Procedure on Overactive Bladder During Pelvic Organ Prolapse Repair Status COMPLETED Phase N/A
NCT02494349 The PK Study of the JLP-1207 and Solifenacin/Tamsulosin in Healthy Male Volunteers. Status COMPLETED Phase PHASE1
NCT02485067 Clinical Study to Assess the Efficacy and Safety of THVD-201 in Patients With OAB Status COMPLETED Phase PHASE3
NCT02476175 Add-on Mirabegron in Pediatric Patients With Refractory Overactive Bladder Status COMPLETED Phase PHASE3
NCT02468830 Pilot Study of Mirabegron in Pediatric Patients With Overactive Bladder Status COMPLETED Phase PHASE3
NCT02468375 Prospective Study for Patient Perception of Treatment Satisfaction After Switching to Mirabegron in Patients With Overactive Bladder Who Were Unsatisfied With Efficacy of Antimuscarinic Therapy or Adverse Event. Status COMPLETED Phase PHASE4